Small but significant: Inter-and intrapatient variations in iPS cell-based disease modeling

Molecular Therapy

Volumn 21, Issue 1, 2013, Pages 5-7

  Sgodda, Malte ^a   Cantz, Tobias ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL POPULATION; CELL RENEWAL; CELL SPECIFICITY; CLINICAL PROTOCOL; COPY NUMBER VARIATION; DISEASE ASSOCIATION; DISEASE MODEL; EPIGENETICS; GENETIC SCREENING; HUMAN; IN VITRO STUDY; MOLECULAR DYNAMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; NUCLEAR REPROGRAMMING; PHENOTYPE; PLURIPOTENT STEM CELL; SEQUENCE ANALYSIS; STEM CELL EXPANSION;

IPS;

EID: 84871852098     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.273     Document Type: Note

References (20)

1. Gurdon, JB (1962). The developmental capacity ofnuclei taken from intestinal epithelium cells of feedingtadpoles. J Embryol Exp Morphol 10: 622-640.
2. Takahashi, K and Yamanaka, S (2006). Induction ofpluripotent stem cells from mouse embryonic andadult fibroblast cultures by defined factors. Cell 126:663-676. (Pubitemid 44233629)
3. Thatava, T, Kudva, YC, Edukulla, R, Squillace, K, DeLamo, JG, Khan, YK et al. (2013). Intrapatient variationsin type 1 diabetes-specific iPS cell differentiation intoinsulin producing cells. Mol Ther 21: 228-239.
4. Gore, A, Li, Z, Fung, HL, Young, JE, Agarwal, S,Antosiewicz-Bourget, J et al. (2011). Somatic codingmutations in human induced pluripotent stem cells.Nature 471: 63-67.
5. Young, MA, Larson, DE, Sun, CW, George, DR, Ding,L, Miller, CA et al. (2012). Background mutations inparental cells account for most of the genetic heterogeneityof induced pluripotent stem cells. Cell Stem Cell10: 570-582.
6. Abyzov, A, Mariani, J, Palejev, D, Zhang, Y, Haney,MS, Tomasini, L et al. (2012). Somatic copy numbermosaicism in human skin revealed by induced pluripotentstem cells. Nature, e-pub ahead of print 18November 2012.
7. Papapetrou, EP, Tomishima, MJ, Chambers, SM, Mica,Y, Reed, E, Menon, J et al. (2009). Stoichiometricand temporal requirements of Oct4, Sox2, Klf4, andc-Myc expression for efficient human iPSC inductionand differentiation. Proc Natl Acad Sci USA 106:12759-12764.
8. Tiemann, U, Sgodda, M, Warlich, E, Ballmaier, M,Schöler, HR, Schambach, A et al. (2011). Optimalreprogramming factor stoichiometry increases colonynumbers and affects molecular characteristics ofmurine induced pluripotent stem cells. Cytometry A79: 426-435.
9. Carey, BW, Markoulaki, S, Hanna, JH, Faddah, DA,Buganim, Y, Kim, J et al. (2011). Reprogrammingfactors stoichiometry influences the epigenetic stateand biological properties of induced pluripotent stemcells. Cell Stem Cell 9: 588-598.
10. Warlich, E, Kuehle, J, Cantz, T, Brugman, MH, Maetzig,T, Galla, M et al. (2011). Lentiviral vector design andimaging approaches to visualize the early stages ofcellular reprogramming. Mol Ther 19: 782-789.
11. Bock, C, Kiskinis, E, Verstappen, G, Gu, H, Boulting,G, Smith, ZD et al. (2011). Reference Maps of humanES and iPS cell variation enable high-throughputcharacterization of pluripotent cell lines. Cell 144:439-452.
12. Hussein, SM, Batada, NN, Vuoristo, S, Ching, RW, Autio,R, Närvä, E et al. (2011). Copy number variationand selection during reprogramming to pluripotency.Nature 471: 58-62.
13. Polo, JM, Liu, S, Figueroa, ME, Kulalert, W, Eminli, S,Tan, KY et al. (2010). Cell type of origin influences themolecular and functional properties of mouse inducedpluripotent stem cells. Nat Biotechnol 28: 848-855.
14. Mayshar, Y, Ben-David, U, Lavon, N, Biancotti, JC, Yakir,B, Clark, AT et al. (2010). Identification and classificationof chromosomal aberrations in human inducedpluripotent stem cells. Cell Stem Cell 7: 521-531.
15. Kroon, E, Martinson, LA, Kadoya, K, Bang, AG, Kelly,OG, Eliazer, S et al. (2008). Pancreatic endodermderived from human embryonic stem cells generatesglucose-responsive insulin-secreting cells in vivo. NatBiotechnol 26: 443-452. (Pubitemid 351501814)
16. Cheng, X, Ying, L, Lu, L, Galvão, AM, Mills, JA, Lin,HC et al. (2012). Self-renewing endodermal progenitorlines generated from human pluripotent stemcells. Cell Stem Cell 10: 371-384.
17. Sakurai, H, Sakaguchi, Y, Shoji, E, Nishino, T, Maki,I, Sakai, H et al. (2012). In vitro modeling of paraxialmesodermal progenitors derived from inducedpluripotent stem cells. PLoS One 7: e47078.
18. Hockemeyer, D, Soldner, F, Beard, C, Gao, Q, Mitalipova,M, DeKelver, RC et al. (2009). Efficient targetingof expressed and silent genes in human ESCsand iPSCs using zinc-finger nucleases. Nat Biotechnol27: 851-857.
19. Bedell, VM, Wang, Y, Campbell, JM, Poshusta, TL,Starker, CG, Krug, RG, 2nd et al. (2012). In vivo genomeediting using a high-efficiency TALEN system.Nature 491: 114-118.
20. Carlson, DF, Fahrenkrug, SC and Hackett, PB (2012).Targeting DNA with fingers and TALENs. Mol TherNucleic Acids 1: e3.